{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:19:13Z","timestamp":1776813553850,"version":"3.51.2"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The endocannabinoid system (ECS) is involved in multiple physiological processes, including appetite regulation, pain perception, motor function development, and immune response regulation. Cannabinoids have been approved for the clinical treatment of nausea and vomiting caused by cytostatic therapy or cancer chemotherapy, loss of appetite in HIV\/AIDS-associated cachexia, refractory spasms induced by multiple sclerosis, chronic pain, and urinary incontinence.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Check out the research on ECS and bone diseases in the past 20\u00a0years.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Many studies have demonstrated that endocannabinoids (eCBs) and cannabinoid receptors (CBRs) are expressed in bone and synovial tissues, playing important roles in bone metabolism. Preclinical studies using cannabis-based therapies in animal models have shown that cannabinoids (CBs) can alleviate the development of osteoarthritis (OA), prevent osteoporosis (OP), reduce cancer-induced osteolytic destruction, and improve fracture healing, highlighting the therapeutic potential of CBs for human bone diseases.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The present review summarizes various components of the ECS in bone diseases and their potential as a therapeutic target.<\/jats:p>","DOI":"10.3389\/fphar.2021.793750","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T13:48:31Z","timestamp":1642772911000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuqi","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2826.2008.01675.x","article-title":"Endocannabinoids and the Regulation of Bone Metabolism","volume":"20","author":"Bab","year":"2008","journal-title":"J. Neuroendocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1476-5381.2011.01474.x","article-title":"Skeletal Lipidomics: Regulation of Bone Metabolism by Fatty Acid Amide Family","volume":"163","author":"Bab","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/15419069809004474","article-title":"Dysregulation of the E-Cadherin\/catenin Complex by Irreversible Mutations in Human Carcinomas","volume":"6","author":"Berx","year":"1998","journal-title":"Cell Adhes. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2015.12.009","article-title":"Effects of Bioactive Fatty Acid Amide Derivatives in Zebrafish Scale Model of Bone Metabolism and Disease","volume":"104","author":"Carnovali","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1476-5381.2009.00629.x","article-title":"Spinal and Peripheral Analgesic Effects of the CB2 Cannabinoid Receptor Agonist AM1241 in Two Models of Bone Cancer-Induced Pain","volume":"160","author":"Curto-Reyes","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B6","first-page":"605","article-title":"Determination and Characterization of a Cannabinoid Receptor in Rat Brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and Structure of a Brain Constituent that Binds to the Cannabinoid Receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MOL.0b013e32803dbdec","article-title":"Endocannabinoids and the Regulation of Their Levels in Health and Disease","volume":"18","author":"Di Marzo","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the Endocannabinoid System: to Enhance or Reduce?","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s11325-019-02009-9","article-title":"CB1 Receptor Antagonist Rimonabant Protects against Chronic Intermittent Hypoxia-Induced Bone Metabolism Disorder and Destruction in Rats","volume":"24","author":"Dou","year":"2020","journal-title":"Sleep Breath"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/can.2015.0001","article-title":"Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies","volume":"1","author":"Dunn","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4155\/fmc.12.20","article-title":"Cannabinoids: Novel Therapies for Arthritis?","volume":"4","author":"Dunn","year":"2012","journal-title":"Future Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1210\/jc.2019-00665","article-title":"Bones and Joints: The Effects of Cannabinoids on the Skeleton","volume":"104","author":"Ehrenkranz","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/all.12858","article-title":"Cannabinoid Receptor 2 Augments Eosinophil Responsiveness and Aggravates Allergen-Induced Pulmonary Inflammation in Mice","volume":"71","author":"Frei","year":"2016","journal-title":"Allergy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1523\/JNEUROSCI.3815-04.2005","article-title":"Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain","volume":"25","author":"Ghilardi","year":"2005","journal-title":"J. Neurosci."},{"key":"B17","first-page":"67","article-title":"Cannabis as a Medicine","volume-title":"Marijuana: The Forbidden Medicine","author":"Grinspoon","year":"1993"},{"key":"B18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3238\/arztebl.2012.0495","article-title":"The Therapeutic Potential of Cannabis and Cannabinoids","volume":"109","author":"Grotenhermen","year":"2012","journal-title":"Dtsch Arztebl Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/rheumatology\/ket447","article-title":"Expression of Cannabinoid Receptor 2 and its Inhibitory Effects on Synovial Fibroblasts in Rheumatoid Arthritis","volume":"53","author":"Gui","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1016\/j.bmcl.2014.11.006","article-title":"The SAR Development of Substituted Purine Derivatives as Selective CB2 Agonists for the Treatment of Chronic Pain","volume":"24","author":"Guidetti","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ijc.23584","article-title":"Expression of Cannabinoid Receptors Type 1 and Type 2 in Non-hodgkin Lymphoma: Growth Inhibition by Receptor Activation","volume":"123","author":"Gustafsson","year":"2008","journal-title":"Int. J. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jnutbio.2010.06.001","article-title":"Eicosapentaenoic Acid Decreases Expression of Anandamide Synthesis Enzyme and Cannabinoid Receptor 2 in Osteoblast-like Cells","volume":"22","author":"Hutchins","year":"2011","journal-title":"J. Nutr. Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.bone.2010.01.368","article-title":"The TRPV1 Ion Channel Antagonist Capsazepine Inhibits Osteoclast and Osteoblast Differentiation In Vitro and Ovariectomy Induced Bone Loss In Vivo","volume":"46","author":"Idris","year":"2010","journal-title":"Bone"},{"key":"B24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00223-010-9378-8","article-title":"Cannabinoids and Bone: Friend or Foe?","volume":"87","author":"Idris","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid Receptor Type 1 Protects against Age-Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm1255","article-title":"Regulation of Bone Mass, Bone Loss and Osteoclast Activity by Cannabinoid Receptors","volume":"11","author":"Idris","year":"2005","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"RA32","DOI":"10.1016\/j.mehy.2008.08.012","article-title":"Matrix Metalloproteinase-2 Involvement in Breast Cancer Progression: a Mini-Review","volume":"15","author":"Jezierska","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"B28","doi-asserted-by":"publisher","first-page":"35471","DOI":"10.1074\/jbc.M110.144758","article-title":"Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment","volume":"285","author":"Jiang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-21737-2_1","article-title":"Endocannabinoid System Components: Overview and Tissue Distribution","volume":"1162","author":"Joshi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2013-204111","article-title":"The Coupling of Bone and Cartilage Turnover in Osteoarthritis: Opportunities for Bone Antiresorptives and Anabolics as Potential Treatments?","volume":"73","author":"Karsdal","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00540-010-0919-0","article-title":"Reduction of Bone Cancer Pain by CB1 Activation and TRPV1 Inhibition","volume":"24","author":"Kawamata","year":"2010","journal-title":"J. Anesth."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/jbmr.2513","article-title":"Cannabidiol, a Major Non-psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts","volume":"30","author":"Kogan","year":"2015","journal-title":"J. Bone Miner Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2013.12.012","article-title":"Rescue of Proinflammatory Cytokine-Inhibited Chondrogenesis by the Antiarthritic Effect of Melatonin in Synovium Mesenchymal Stem Cells via Suppression of Reactive Oxygen Species and Matrix Metalloproteinases","volume":"68","author":"Liu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/BOR.0000000000000590","article-title":"Joints for Joints: Cannabinoids in the Treatment of Rheumatoid Arthritis","volume":"31","author":"Lowin","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jbmr.1732","article-title":"Disease Modification of Breast Cancer-Induced Bone Remodeling by Cannabinoid 2 Receptor Agonists","volume":"28","author":"Lozano-Ondoua","year":"2013","journal-title":"J. Bone Miner Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.lfs.2010.02.014","article-title":"A Cannabinoid 2 Receptor Agonist Attenuates Bone Cancer-Induced Pain and Bone Loss","volume":"86","author":"Lozano-Ondoua","year":"2010","journal-title":"Life Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid Signaling at the Periphery: 50 Years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The Nonpsychoactive Cannabis Constituent Cannabidiol Is an Oral Anti-arthritic Therapeutic in Murine Collagen-Induced Arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ebiom.2019.05.048","article-title":"Paradoxical Effects of JZL184, an Inhibitor of Monoacylglycerol Lipase, on Bone Remodelling in Healthy and Cancer-Bearing Mice","volume":"44","author":"Marino","year":"2019","journal-title":"EBioMedicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.phrs.2017.02.023","article-title":"Emerging Therapeutic Targets in Cancer Induced Bone Disease: A Focus on the Peripheral Type 2 Cannabinoid Receptor","volume":"119","author":"Marino","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1211\/jpp.58.3.0009","article-title":"Arthritis and Cannabinoids: HU-210 and Win-55,212-2 Prevent IL-1alpha-induced Matrix Degradation in Bovine Articular Chondrocytes In-Vitro","volume":"58","author":"Mbvundula","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.gene.2005.11.004","article-title":"Evolutionary Origins of the Endocannabinoid System","volume":"370","author":"McPartland","year":"2006","journal-title":"Gene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-d","article-title":"Identification of an Endogenous 2-monoglyceride, Present in Canine Gut, that Binds to Cannabinoid Receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"B44","first-page":"1","article-title":"The Pharmacohistory of Cannabis Sativa","volume-title":"Cannabinoids as Therapeutic Agents","author":"Mechoulam","year":"1986"},{"key":"B45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular Characterization of a Peripheral Receptor for Cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3892\/ol.2015.3525","article-title":"Potentiation of the Antitumor Activity of Adriamycin against Osteosarcoma by Cannabinoid WIN-55,212-2","volume":"10","author":"Niu","year":"2015","journal-title":"Oncol. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral Cannabinoid Receptor, CB2, Regulates Bone Mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1902\/jop.2016.150612","article-title":"Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist HU-308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis","volume":"87","author":"Ossola","year":"2016","journal-title":"J. Periodontol."},{"key":"B49","first-page":"1","article-title":"Pharmacological Actions of Cannabinoids","volume-title":"Handb Exp. Pharmacol.","author":"Pertwee","year":"2005"},{"key":"B50","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: beyond CB\u2081 and CB\u2082","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2174\/092986710790980050","article-title":"Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists","volume":"17","author":"Pertwee","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid Receptors and Their Ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/sj.onc.1210641","article-title":"Delta9-Tetrahydrocannabinol Inhibits Epithelial Growth Factor-Induced Lung Cancer Cell Migration In Vitro as Well as its Growth and Metastasis In Vivo","volume":"27","author":"Preet","year":"2008","journal-title":"Oncogene"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1158\/1535-7163.MCT-09-0448","article-title":"Synthetic Cannabinoid Receptor Agonists Inhibit Tumor Growth and Metastasis of Breast Cancer","volume":"8","author":"Qamri","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/ar2401","article-title":"Characterisation of the Cannabinoid Receptor System in Synovial Tissue and Fluid in Patients with Osteoarthritis and Rheumatoid Arthritis","volume":"10","author":"Richardson","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/dta.1529","article-title":"Therapeutic Potential of Cannabinoid Medicines","volume":"6","author":"Robson","year":"2014","journal-title":"Drug Test. Anal."},{"key":"B57","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.bone.2011.01.001","article-title":"The Endovanilloid\/endocannabinoid System: a New Potential Target for Osteoporosis Therapy","volume":"48","author":"Rossi","year":"2011","journal-title":"Bone"},{"key":"B58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bone.2008.10.056","article-title":"The Endovanilloid\/endocannabinoid System in Human Osteoclasts: Possible Involvement in Bone Formation and Resorption","volume":"44","author":"Rossi","year":"2009","journal-title":"Bone"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081919","article-title":"The Endocannabinoid\/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma","volume":"20","author":"Rossi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.pain.2010.11.025","article-title":"Local Application of the Endocannabinoid Hydrolysis Inhibitor URB597 Reduces Nociception in Spontaneous and Chemically Induced Models of Osteoarthritis","volume":"152","author":"Schuelert","year":"2011","journal-title":"Pain"},{"key":"B61","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/ani9090686","article-title":"The Endocannabinoid System of Animals","volume":"9","author":"Silver Robert","year":"2019","journal-title":"Animals (Basel)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"8774","DOI":"10.1073\/pnas.1503395112","article-title":"CB2 Cannabinoid Receptor Agonist Enantiomers HU-433 and HU-308: An Inverse Relationship between Binding Affinity and Biological Potency","volume":"112","author":"Smoum","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.joca.2015.04.020","article-title":"The Type 2 Cannabinoid Receptor Regulates Susceptibility to Osteoarthritis in Mice","volume":"23","author":"Sophocleous","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/acel.12638","article-title":"Combined Deficiency of the Cnr1 and Cnr2 Receptors Protects against Age-Related Bone Loss by Osteoclast Inhibition","volume":"16","author":"Sophocleous","year":"2017","journal-title":"Aging Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/art.20050","article-title":"A Novel Synthetic, Nonpsychoactive Cannabinoid Acid (HU-320) with Antiinflammatory Properties in Murine Collagen-Induced Arthritis","volume":"50","author":"Sumariwalla","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3892\/etm.2013.1390","article-title":"Role of Nuclear Factor of Activated T Cells 1 in the Pathogenesis of Osteoarthritis","volume":"7","author":"Sun","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1124\/mol.106.026435","article-title":"Involvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling","volume":"70","author":"Tam","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1096\/fj.06-7957com","article-title":"The Cannabinoid CB1 Receptor Regulates Bone Formation by Modulating Adrenergic Signaling","volume":"22","author":"Tam","year":"2008","journal-title":"FASEB J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1111\/j.1476-5381.2011.01519.x","article-title":"Cannabinoids and Bone: Endocannabinoids Modulate Human Osteoclast Function In Vitro","volume":"165","author":"Whyte","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The Putative Cannabinoid Receptor GPR55 Affects Osteoclast Function In Vitro and Bone Mass In Vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e12691","DOI":"10.1111\/cpr.12691","article-title":"CB1 Enhanced the Osteo\/dentinogenic Differentiation Ability of Periodontal Ligament Stem Cells via P38 MAPK and JNK in an Inflammatory Environment","volume":"52","author":"Yan","year":"2019","journal-title":"Cell Prolif"},{"key":"B72","doi-asserted-by":"publisher","first-page":"362126","DOI":"10.1155\/2015\/362126","article-title":"Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-inflammation against Lipopolysaccharide in MG-63 Cells","volume":"2015","author":"Yang","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.clinthera.2013.09.022","article-title":"Longitudinal Use of Complementary and Alternative Medicine Among Older Adults with Radiographic Knee Osteoarthritis","volume":"35","author":"Yang","year":"2013","journal-title":"Clin. Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"104525","DOI":"10.1016\/j.archoralbio.2019.104525","article-title":"CoCl2 Induced Hypoxia Enhances Osteogenesis of Rat Bone Marrow Mesenchymal Stem Cells through Cannabinoid Receptor 2","volume":"108","author":"Zhang","year":"2019","journal-title":"Arch. Oral Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.793750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T13:48:38Z","timestamp":1642772918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.793750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":74,"alternative-id":["10.3389\/fphar.2021.793750"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.793750","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"article-number":"793750"}}